Aberrant expression of sialidase and cancer progression

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Aberrant sialylation is a hallmark of cancer, correlating with malignant traits like metastasis and invasiveness.
• The precise biological roles and molecular mechanisms of aberrant sialylation in cancer remain incompletely understood.
• Mammalian sialidases, enzymes that cleave sialic acids, are key players in regulating sialylation.

Purpose of the Study:

• To investigate the causes and consequences of aberrant sialylation in cancer.
• To elucidate the distinct roles of different human sialidase types in carcinogenesis.
• To summarize research findings on sialidase expression and their involvement in cancer progression.

Main Methods:

• Focus on mammalian sialidases, enzymes responsible for cleaving sialic acids from glycoproteins and gangliosides.
• Analysis of the differential expression patterns of human sialidases during carcinogenesis.
• Review of experimental results concerning sialidase expression and function in cancer.

Main Results:

• Two key human sialidases exhibit opposing expression patterns in cancer: lysosomal sialidase is down-regulated, while plasma membrane sialidase is up-regulated.
• Down-regulation of lysosomal sialidase promotes anchorage-independent growth and enhances metastatic potential.
• Up-regulation of plasma membrane sialidase contributes to the suppression of apoptosis in cancer cells.

Conclusions:

• Aberrant expression of specific human sialidases plays a significant role in cancer progression.
• Lysosomal and plasma membrane sialidases have distinct, often opposing, functions in the context of cancer malignancy.
• Understanding sialidase roles offers potential insights into novel therapeutic strategies targeting cancer metastasis and survival.